Skip to content

In the BioHarmony Drug Report Database

Hydroxocobalamin

Cyanokit (hydroxocobalamin) is a small molecule pharmaceutical. Hydroxocobalamin was first approved as Cyanokit on 2006-12-15. It is used to treat alcoholic neuropathy, diabetic neuropathies, multiple sclerosis, pernicious anemia, and poisoning in the USA. It has been approved in Europe to treat poisoning.
Trade Name Cyanokit
Common Name Hydroxocobalamin
Indication alcoholic neuropathy, diabetic neuropathies, multiple sclerosis, pernicious anemia, poisoning
Drug Class
Hydroxocobalamin
Get full access now